H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

智通财经APP获悉，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals ...

丹麦瓦尔比和美国加利福尼亚州拉霍亚 - H. Lundbeck A/S (Lundbeck)和Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) (Longboard)已达成协议，Lundbeck将收购临床阶段生物制药公司Longboard。这笔交易的股权价值约为26亿美元，扣除现金后净值为25亿美元。此次收购将通过增加Longboard的主要资产bexi ...

周一，尽管目标价从45美元上调至60美元，B.Riley分析师仍将Longboard Pharmaceuticals Inc (NASDAQ:LBPH)的评级从买入下调至中性。这一调整是在Longboard宣布与Lundbeck达成约26亿美元的收购协议后做出的，收购价格相当于每股60美元。这一收购价格较Longboard截至2024年9月30日的30天成交量加权平均股价溢价77%。 Longbo ...

两家公司周一表示，Lundbeck将以每股60美元的现金收购Longboard，较Longboard上周五38.90美元的收盘价溢价54%。此外，两家公司表示，该交易预计于今年年底完成，扣除Longboard现金后的价值约为25亿美元。

Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious ...

(Reuters) -H Lundbeck A/S has agreed to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion, marking the biggest deal ...

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...

After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is ...

H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing ...

Longboard Pharmaceuticals ($LBPH) soared in trading on Monday after announcing that Dutch pharmaceutical company Lundbeck ...

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the ...